Page last updated: 2024-08-16

temozolomide and aurintricarboxylic acid

temozolomide has been researched along with aurintricarboxylic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berens, ME; Chow, D; Dhruv, HD; Hartman, LK; Inge, LJ; Kloss, J; Loftus, JC; Mathews, IT; Millard, N; Roos, A; Tran, NL; Tuncali, S; Winkles, JA; Yin, HH	1

Other Studies

1 other study(ies) available for temozolomide and aurintricarboxylic acid

Article	Year
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Oncotarget, 2017, Feb-14, Volume: 8, Issue:7 Topics: Animals; Antineoplastic Agents, Alkylating; Aurintricarboxylic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cytokine TWEAK; Dacarbazine; Drug Synergism; Glioblastoma; HEK293 Cells; Humans; Kaplan-Meier Estimate; Mice, Nude; Molecular Structure; Receptors, Tumor Necrosis Factor; RNA Interference; Signal Transduction; Small Molecule Libraries; Temozolomide; Tumor Necrosis Factors; TWEAK Receptor; Xenograft Model Antitumor Assays	2017

Article

Year

Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.

Oncotarget, 2017, Feb-14, Volume: 8, Issue:7

Topics: Animals; Antineoplastic Agents, Alkylating; Aurintricarboxylic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cytokine TWEAK; Dacarbazine; Drug Synergism; Glioblastoma; HEK293 Cells; Humans; Kaplan-Meier Estimate; Mice, Nude; Molecular Structure; Receptors, Tumor Necrosis Factor; RNA Interference; Signal Transduction; Small Molecule Libraries; Temozolomide; Tumor Necrosis Factors; TWEAK Receptor; Xenograft Model Antitumor Assays

2017